Cubist Systematic Strategies’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,195
| Closed | -$206K | – | 3761 |
|
|
2021
Q3 | $206K | Sell |
1,195
-12,572
| -91% | -$2.17M | ﹤0.01% | 2574 |
|
|
2021
Q2 | $1.73M | Buy |
+13,767
| New | +$1.73M | 0.02% | 1175 |
|
|
2020
Q4 | – | Sell |
-4,000
| Closed | -$450K | – | 2787 |
|
|
2020
Q3 | $450K | Sell |
4,000
-60,457
| -94% | -$6.8M | 0.01% | 1813 |
|
|
2020
Q2 | $6.14M | Buy |
64,457
+53,742
| +502% | +$5.12M | 0.11% | 249 |
|
|
2020
Q1 | $963K | Sell |
10,715
-27,828
| -72% | -$2.5M | 0.03% | 859 |
|
|
2019
Q4 | $2.04M | Buy |
38,543
+35,839
| +1,325% | +$1.9M | 0.04% | 737 |
|
|
2019
Q3 | $107K | Sell |
2,704
-13,853
| -84% | -$548K | ﹤0.01% | 1930 |
|
|
2019
Q2 | $680K | Buy |
16,557
+11,857
| +252% | +$487K | 0.01% | 1284 |
|
|
2019
Q1 | $219K | Buy |
+4,700
| New | +$219K | 0.01% | 1717 |
|
|
2018
Q4 | – | Sell |
-806
| Closed | -$46K | – | 2344 |
|
|
2018
Q3 | $46K | Sell |
806
-4,533
| -85% | -$259K | ﹤0.01% | 1703 |
|
|
2018
Q2 | $259K | Buy |
+5,339
| New | +$259K | 0.01% | 1185 |
|
|
2017
Q4 | – | Sell |
-1,506
| Closed | -$56K | – | 2169 |
|
|
2017
Q3 | $56K | Buy |
+1,506
| New | +$56K | ﹤0.01% | 1720 |
|
|
2017
Q2 | – | Sell |
-200
| Closed | -$5K | – | 1949 |
|
|
2017
Q1 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 1583 |
|
|
2016
Q2 | – | Sell |
-19,691
| Closed | -$520K | – | 1950 |
|
|
2016
Q1 | $520K | Buy |
+19,691
| New | +$520K | 0.03% | 736 |
|